Download 
|
< Back |
| 12 Nov 2025 | |
| Board of Directors of the Company has inter alia 1. Approved the unaudited standalone and consolidate financial results for the quarter ended 30.09.2025. 2. Appointed Dr.B.Mukesh ( DIN # 11295580)as additional Director of the Company. | |
| View all announcements for Bal Pharma Ltd | Source: BSE India |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback